Preferred Label : sulfasalazine;
MeSH definition : A drug that is used in the management of inflammatory bowel diseases. Its activity
is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic
acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia,
30th ed, p907);
MeSH synonym : salicylazosulfapyridine; sulphasalazine; salazosulfapyridine;
CISMeF synonym : azulfidine en tabs; azulfidine en-tabs; pharmacia brand 1 of sulfasalazine; pharmacia brand 2 of sulfasalazine; sanofi synthelabo brand of sulfasalazine; ratiopharm brand of sulfasalazine; alphapharm brand of sulfasalazine; heyl brand of sulfasalazine; FNA brand of sulfasalazine; ashbourne brand of sulfasalazine; azulfadine; salazopyrin; pfizer brand of sulfasalazine; sulfasalazine pfizer brand; pyralin EN; EN, azulfidine; medac brand of sulfasalazine; henning berlin brand of sulfasalazine;
DeCS synonym : Pyralin EN; Salazopyrin; Azulfadine;
MeSH hyponym : sulfasalazin medac; Sulfasalazin-Heyl; azulfidine; ratio-Sulfasalazine; ulcol; ucine; sulfasalazine FNA; Colo-Pleon; Azulfidine EN; Asulfidine; Colo Pleon; Pleon; Sulfasalazin Heyl; ratio Sulfasalazine;
MeSH CAS label : benzoic acid, 2-hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)-;
MeSH Related Number : 599-79-1 (Sulfasalazine);
Registry Number MeSH : 599-79-1;
Wikipedia link : https://en.wikipedia.org/wiki/Sulfasalazine;
Codes EINECS : 209-974-3;
Is substance : O;
UNII : 3XC8GUZ6CB;
InChIKey : NCEXYHBECQHGNR-QZQOTICOSA-N;
Origin ID : D012460;
UMLS CUI : C0036078;
ATC code(s)
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
- TL-118 [MeSH Supplementary Concept]
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A drug that is used in the management of inflammatory bowel diseases. Its activity
is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic
acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia,
30th ed, p907)
https://www.rheuma-net.ch/fr/doc/sulfasalazine/viewdocument/353
2024
Switzerland
guideline
Sulfasalazine
sulfasalazine
sulfasalazine
Background Treatment
---
https://www.has-sante.fr/portail/jcms/c_2908481/fr/salazopyrine
https://www.has-sante.fr/portail/jcms/c_2908481/fr/salazopyrine-sulfasalazine-aminosalicyle
2019
false
true
false
false
France
arthritis, rheumatoid
sulfasalazine
insurance, health, reimbursement
colitis, ulcerative
crohn disease
gastrointestinal agents
anti-inflammatory agents, non-steroidal
colitis, ulcerative
guidelines for drug use
evaluation of the transparency committee
salazopyrine
sulfasalazine
---
http://www.lecrat.eu/?s=Sulfasalazine
2014
false
France
French
sulfasalazine
pregnancy
antirheumatic agents
gastrointestinal agents
anti-inflammatory agents, non-steroidal
breast feeding
salazopyrine
sulfasalazine
sulfasalazine
drug combinations
glucosamine
drug information
---
http://www.has-sante.fr/portail/jcms/c_1759083/fr/salazopyrine
http://www.has-sante.fr/portail/jcms/c_1759083/fr/salazopyrine-traitements-de-fond-non-biologiques-de-la-polyarthrite-rhumatoide-hors-methotrexate-et-leflunomide
2014
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
insurance, health, reimbursement
sulfasalazine
sulfasalazine
gastrointestinal agents
antirheumatic agents
anti-inflammatory agents, non-steroidal
arthritis, rheumatoid
colitis, ulcerative
crohn disease
guidelines for drug use
---
http://www.cochrane.org/fr/CD000543
http://www.cochrane.org/fr/CD000543/acide-5-aminosalicylique-oral-dans-le-traitement-dune-colite-ulcereuse-active
2012
false
true
false
United Kingdom
France
treatment outcome
administration, oral
comparative study
sulfasalazine
mesalamine
sulfasalazine
anti-inflammatory agents
anti-inflammatory agents
remission induction
meta-analysis
french abstract
colitis, ulcerative
mesalamine
---
http://www.cochrane.org/fr/CD000958
2010
United Kingdom
France
French
review of literature
arthritis, rheumatoid
treatment outcome
sulfasalazine
antirheumatic agents
french abstract
---
http://www.cochrane.org/fr/CD004800
2009
false
true
false
United Kingdom
France
treatment outcome
meta-analysis
french abstract
sulfasalazine
spondylitis, ankylosing
---